The report provides a detailed analysis essential for establishing a Diethylamine Salicylate production plant. It encompasses all critical aspects necessary for Diethylamine Salicylate production, including the cost of Diethylamine Salicylate production, Diethylamine Salicylate plant cost, Diethylamine Salicylate production costs, and the overall Diethylamine Salicylate production plant cost. Additionally, the study covers specific expenditures associated with setting up and operating a Diethylamine Salicylate production plant. These encompass production processes, raw material requirements, utility requirements, infrastructure needs, machinery and technology requirements, manpower requirements, packaging requirements, transportation requirements, and more.
Diethylamine salicylate is a topical non-steroidal anti-inflammatory drug (NSAID) primarily used in industrial applications. It is commonly formulated into creams, ointments, and gels for the relief of pain and inflammation related to rheumatic conditions, arthritis, muscle strains, sprains, and minor musculoskeletal injuries. Its effectiveness is due to its mechanism of inhibiting cyclo-oxygenases (COX-1 and COX-2), reducing pain-inducing prostaglandins, and its enhanced skin penetration compared to sodium salicylate.
The market demand for diethylamine salicylate is driven by its applications as a topical analgesic and anti-inflammatory agent, which elevates its demand in the pharmaceutical industry. The global ageing population results in increased prevalence of arthritis and musculoskeletal disorders (MSDs) affecting hundreds of millions worldwide. This demographic shift fuels demand for effective pain relief products like diethylamine salicylate. The global rise in the incidence of musculoskeletal disorders and chronic pain globally, including injuries from industrial accidents and road traffic accidents, creates a steady requirement for topical pain therapies.
Growing consumer awareness and preference for topical analgesics as safer alternatives to systemic painkillers, due to lower side effects and localised action propel the demand for diethylamine salicylate. Diethylamine salicylate's superior skin penetration compared to other salicylates enhances its effectiveness and market preference. Additionally, increasing research funding and new therapies for neuromuscular diseases and pain management expand opportunities for diethylamine salicylate. Industrial diethylamine salicylate procurement depends heavily on the availability and price fluctuations of key raw materials, especially salicylic acid and diethylamine. The industrial synthesis requires controlled reaction conditions and purification steps (e.g., recrystallisation), further influencing procurement.
Raw Material for Diethylamine Salicylate Production
According to the Diethylamine Salicylate production plant project report, the various raw materials for Diethylamine Salicylate production include salicylic acid- diethylamine.
Production Process of Diethylamine Salicylate
The extensive Diethylamine Salicylate production cost report consists of the following major industrial production process:
- Production from salicylic acid with diethylamine: The production process of diethylamine salicylate initiates with the reaction of salicylic acid with diethylamine, and subsequent neutralisation and purification. In production, equimolar amounts of salicylic acid and diethylamine are mixed in water and heated to about 100 degree Celsius for 20–30 minutes under agitation to complete the acid-base neutralisation, forming the diethylamine salt. In the final step, the water is evaporated to concentrate the product and induce crystallisation, which is followed by recrystallisation from water or ethanol for higher purity.
Properties of Diethylamine Salicylate
Diethylamine salicylate is a white to off-white crystalline solid with a molecular formula of C11H17NO3 and a molecular weight of 211.26 g/mol. It appears as a pale yellow to white powder and has limited solubility in water but slight solubility in organic solvents such as acetonitrile, chloroform, and methanol. Its melting point ranges from about 99 degree Celsius to 125 degree Celsius, depending on the source, and it has a flash point of around 55 degree Celsius at atmospheric pressure.
The compound is characterised by its analgesic, anti-inflammatory, bacteriostatic, fungicidal, and keratolytic properties, making it suitable for topical pharmaceutical formulations. Its pH in aqueous solution ranges from neutral to slightly basic (around 6.8 to 7.2). Due to its chemical nature, it may cause skin irritation or allergic reactions, so proper handling and protective measures are recommended in industrial and laboratory settings.